Diabetes mellitus and traffic incidents

Insulin-treated diabetes and driving: what is the patient’s knowledge of current regulations?

“…9 Patient awareness of this guideline is important because of the well documented relationship between driving performance and hypoglycaemia. 1,12 Ten per cent of participants reported some restrictions on repeat prescriptions for test-strips from GPs. Many participants, however, failed to elaborate adequately on the extent of these restrictions.…”

Insulin-treated diabetes and driving: what is the patient’s knowledge of current regulations?

“…9 Patient awareness of this guideline is important because of the well documented relationship between driving performance and hypoglycaemia. 1,12 Ten per cent of participants reported some restrictions on repeat prescriptions for test-strips from GPs. Many participants, however, failed to elaborate adequately on the extent of these restrictions.…”

Blood Glucose Awareness Training in Dutch Type 1 diabetes patients. Short‐term evaluation of individual and group training

“…Neuroglycopenia affects the ability to react instantly in a complex situation, like traffic. During hypoglycaemia, the risk of traffic accidents is increased [13]. Relatively mild levels of hypoglycaemia have been shown to disrupt driving behaviour [14], and although patients are aware of their impairment, they hesitate to raise their bg under these circumstances [15].…”

“…The percentage of decisions to drive (hhc) while the actual bg was < 3.6 mmol/l. Driving simulator experiments show significant impairments in driving performance at this level of hypoglycaemia [13].…”

Insight into hypoglycemia in pediatric type 1 diabetes mellitus

“…Hypoglycemia can affect patients' relationships, occupation, and daily activities such as driving [17,18]. However, one of the greatest impacts is patients' fear of severe hypoglycemic events, which is a limiting factor in the optimization of glycemic control [19,20].…”

“…These events result in transient cognitive defects, which can impact concurrent activities such as driving [18], but these fortuitously fail to show long-term cognitive consequences. Specifically, the DCCT showed that neither treatment regimen (conventional vs. multiple daily injection therapy) nor frequencies of severe hypoglycemia were associated with a cognitive decline over a mean 18 year follow up [42-44].…”

Insulin-treated diabetes and driving: what is the patient’s knowledge of current regulations?

“…9 Patient awareness of this guideline is important because of the well documented relationship between driving performance and hypoglycaemia. 1,12 Ten per cent of participants reported some restrictions on repeat prescriptions for test-strips from GPs. Many participants, however, failed to elaborate adequately on the extent of these restrictions.…”

Blood Glucose Awareness Training in Dutch Type 1 diabetes patients. Short‐term evaluation of individual and group training

“…Neuroglycopenia affects the ability to react instantly in a complex situation, like traffic. During hypoglycaemia, the risk of traffic accidents is increased [13]. Relatively mild levels of hypoglycaemia have been shown to disrupt driving behaviour [14], and although patients are aware of their impairment, they hesitate to raise their bg under these circumstances [15].…”

“…The percentage of decisions to drive (hhc) while the actual bg was < 3.6 mmol/l. Driving simulator experiments show significant impairments in driving performance at this level of hypoglycaemia [13].…”

Insight into hypoglycemia in pediatric type 1 diabetes mellitus

“…Hypoglycemia can affect patients' relationships, occupation, and daily activities such as driving [17,18]. However, one of the greatest impacts is patients' fear of severe hypoglycemic events, which is a limiting factor in the optimization of glycemic control [19,20].…”

“…These events result in transient cognitive defects, which can impact concurrent activities such as driving [18], but these fortuitously fail to show long-term cognitive consequences. Specifically, the DCCT showed that neither treatment regimen (conventional vs. multiple daily injection therapy) nor frequencies of severe hypoglycemia were associated with a cognitive decline over a mean 18 year follow up [42-44].…”

Insulin-treated diabetes and driving: what is the patient’s knowledge of current regulations?

“…9 Patient awareness of this guideline is important because of the well documented relationship between driving performance and hypoglycaemia. 1,12 Ten per cent of participants reported some restrictions on repeat prescriptions for test-strips from GPs. Many participants, however, failed to elaborate adequately on the extent of these restrictions.…”

Blood Glucose Awareness Training in Dutch Type 1 diabetes patients. Short‐term evaluation of individual and group training

“…Neuroglycopenia affects the ability to react instantly in a complex situation, like traffic. During hypoglycaemia, the risk of traffic accidents is increased [13]. Relatively mild levels of hypoglycaemia have been shown to disrupt driving behaviour [14], and although patients are aware of their impairment, they hesitate to raise their bg under these circumstances [15].…”

“…The percentage of decisions to drive (hhc) while the actual bg was < 3.6 mmol/l. Driving simulator experiments show significant impairments in driving performance at this level of hypoglycaemia [13].…”

Insight into hypoglycemia in pediatric type 1 diabetes mellitus

“…Hypoglycemia can affect patients' relationships, occupation, and daily activities such as driving [17,18]. However, one of the greatest impacts is patients' fear of severe hypoglycemic events, which is a limiting factor in the optimization of glycemic control [19,20].…”

“…These events result in transient cognitive defects, which can impact concurrent activities such as driving [18], but these fortuitously fail to show long-term cognitive consequences. Specifically, the DCCT showed that neither treatment regimen (conventional vs. multiple daily injection therapy) nor frequencies of severe hypoglycemia were associated with a cognitive decline over a mean 18 year follow up [42-44].…”